Type 1 Diabetes Autonomic and Vascular Function
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Jan 15, 2025
Trial Information
Current as of August 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Elevated blood glucose levels in individuals with type 1 diabetes can result in both microvascular and macrovascular complications. Research conducted by Song et al. revealed that children with type 1 diabetes exhibit abnormal cerebral perfusion. Additionally, autonomic mechanisms are affected in type 1 diabetes, as indicated in an animal study which demonstrated that the exercise pressor reflex is exaggerated in both male and female rats during the early stages of the disease. However, whether this also occurs in human patients with type 1 diabetes remains unknown.
Therefore, in this stud...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Type 1 diabetes or a Healthy control
- Exclusion Criteria:
- • BMI \> 40kg/m2
- • Cancer with current treatment
- • HIV
- • Smoker cigarettes
- • Are pregnant or breastfeeding
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported